Initial viral load in cases of single human papillomavirus 16 or 52 persistent infection is associated with progression of later cytopathological findings in the uterine cervix

The aim of this study was to investigate the relationship between viral load in single human papillomavirus (HPV) 16 or 52 persistent infection and the progression of later cytopathological findings in the uterine cervix. Cervical cytology and HPV genotyping tests were repeated within 3–6 months in 305 women with oncogenic HPV. Twenty‐four cases of single HPV 52 persistent infection and 24 cases of single HPV 16 persistent infection were identified. Cases with later cytopathological findings showing progression were defined as the progression group, while those with no change or regression were the non‐progression group. Relative HPV DNA loads were determined by quantitative real‐time polymerase chain reaction and expressed relative to human albumin (ALB) DNA. Differences between the two groups were evaluated. The median relative HPV 52 DNA load was 2.211 in the progression group and 0.022 in the non‐progression group (Mann–Whitney U‐test, P = 0.003). The median relative HPV 16 DNA load was 4.206 in the progression group and 0.103 in the non‐progression group (P = 0.001). HPV 52 and 16 DNA loads assessed by quantitative real‐time methods may be useful short‐term markers for identifying women at high risk for progression of cervical cytological pathology. J. Med. Virol. 85:2093–2100, 2013. © 2013 Wiley Periodicals, Inc.

[1]  K. Kapila,et al.  Viral load of human papillomavirus in women with normal and abnormal cervical cytology in Kuwait. , 2013, Journal of infection in developing countries.

[2]  D. Olive,et al.  Two years outcome of women infected with high risk HPV having normal colposcopy following low‐grade or equivocal cytological abnormalities: Are HPV16 and 18 viral load clinically useful predictive markers? , 2012, Journal of medical virology.

[3]  M. Sherman,et al.  Human Papillomavirus Load Measured by Linear Array Correlates with Quantitative PCR in Cervical Cytology Specimens , 2012, Journal of Clinical Microbiology.

[4]  K. Yoshiura,et al.  Pre‐vaccination epidemiology of human papillomavirus infections in Japanese women with abnormal cytology , 2011, The journal of obstetrics and gynaecology research.

[5]  D. Celentano,et al.  Kinetics of DNA load predict HPV 16 viral clearance. , 2011, Journal of clinical virology : the official publication of the Pan American Society for Clinical Virology.

[6]  M. Inoue,et al.  Adoption of HPV testing as an adjunct to conventional cytology in cervical cancer screening in Japan , 2010, International journal of gynaecology and obstetrics: the official organ of the International Federation of Gynaecology and Obstetrics.

[7]  A. Botezatu,et al.  The relationship between HPV16 and HPV18 viral load and cervical lesions progression. , 2009, Roumanian archives of microbiology and immunology.

[8]  C. Wheeler,et al.  Human papillomavirus type 18 DNA load and 2-year cumulative diagnoses of cervical intraepithelial neoplasia grades 2-3. , 2009, Journal of the National Cancer Institute.

[9]  H. Masuzaki,et al.  Genital human papilloma virus infection in mentally-institutionalized virgins. , 2007, Gynecologic oncology.

[10]  S. Franceschi,et al.  Human papillomavirus type distribution in invasive cervical cancer and high‐grade cervical lesions: A meta‐analysis update , 2007, International journal of cancer.

[11]  T. Sano,et al.  Quantitative real-time polymerase chain reaction analysis of the type distribution, viral load, and physical status of human papillomavirus in liquid-based cytology samples from cervical lesions , 2007, International Journal of Gynecologic Cancer.

[12]  H. Richet,et al.  Determination of HPV type 16 and 18 viral load in cervical smears of women referred to colposcopy , 2006, Journal of medical virology.

[13]  N. Lalaoui,et al.  Dynamics of HPV16 DNA load reflect the natural history of cervical HPV-associated lesions. , 2006, Journal of clinical virology : the official publication of the Pan American Society for Clinical Virology.

[14]  T. Cheung,et al.  Quantitative analysis of human papillomavirus type 16 in cervical neoplasm: a study in Chinese population. , 2005, Journal of clinical virology : the official publication of the Pan American Society for Clinical Virology.

[15]  U. Gyllensten,et al.  High viral loads of human papillomavirus predict risk of invasive cervical carcinoma , 2005, British Journal of Cancer.

[16]  K. Kariya,et al.  A large case-control study of cervical cancer risk associated with human papillomavirus infection in Japan, by nucleotide sequencing-based genotyping. , 2004, The Journal of infectious diseases.

[17]  J. Sautière,et al.  Persistence and load of high‐risk HPV are predictors for development of high‐grade cervical lesions: A longitudinal French cohort study , 2003, International journal of cancer.

[18]  U. Gyllensten,et al.  Real-Time PCR-Based System for Simultaneous Quantification of Human Papillomavirus Types Associated with High Risk of Cervical Cancer , 2003, Journal of Clinical Microbiology.

[19]  M. Sherman,et al.  A comparison between real-time polymerase chain reaction and hybrid capture 2 for human papillomavirus DNA quantitation. , 2003, Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology.

[20]  F. X. Bosch,et al.  Epidemiologic classification of human papillomavirus types associated with cervical cancer. , 2003, The New England journal of medicine.

[21]  A. Berger,et al.  Viral genome quantification as a tool for improving patient management: the example of HIV, HBV, HCV and CMV. , 2002, The Journal of antimicrobial chemotherapy.

[22]  P. Snijders,et al.  Human papillomavirus 16 load in normal and abnormal cervical scrapes: An indicator of CIN II/III and viral clearance , 2002, International journal of cancer.

[23]  S. Nieh,et al.  Viral load of high‐risk human papillomavirus in cervical squamous intraepithelial lesions , 2002, International journal of gynaecology and obstetrics: the official organ of the International Federation of Gynaecology and Obstetrics.

[24]  T. Rohan,et al.  Persistent human papillomavirus infection as a predictor of cervical intraepithelial neoplasia. , 2001, JAMA.

[25]  A. Moscicki,et al.  Risks for incident human papillomavirus infection and low-grade squamous intraepithelial lesion development in young females. , 2001, JAMA.

[26]  C. Woodman,et al.  Natural history of cervical human papillomavirus infection in young women: a longitudinal cohort study , 2001, The Lancet.

[27]  H. Adami,et al.  Consistent high viral load of human papillomavirus 16 and risk of cervical carcinoma in situ: a nested case-control study , 2000, The Lancet.

[28]  H. Adami,et al.  Viral load of human papilloma virus 16 as a determinant for development of cervical carcinoma in situ: a nested case-control study , 2000, The Lancet.

[29]  David R. Scott,et al.  Improved Amplification of Genital Human Papillomaviruses , 2000, Journal of Clinical Microbiology.

[30]  J. Peto,et al.  Human papillomavirus is a necessary cause of invasive cervical cancer worldwide , 1999, The Journal of pathology.

[31]  L Beardsley,et al.  Natural history of cervicovaginal papillomavirus infection in young women. , 1998, The New England journal of medicine.

[32]  G. Schoolnik,et al.  Variability of Human Papillomavirus DNA Testing in a Longitudinal Cohort of Young Women , 1993, Obstetrics and gynecology.

[33]  Cdm Fletcher,et al.  World Health Organization Classification of Tumours , 2002 .

[34]  J. Higginson International Agency for Research on Cancer. , 1968, WHO chronicle.